Stocks / Max Healthcare Institute (MAXHEALTH)

MAXHEALTH Share Price, Analysis & News

Max Healthcare Institute (MAXHEALTH) — Updated on 2026-05-08

Max Healthcare Institute Limited is an India-based integrated healthcare provider operating within the healthcare facilities industry. The company's operations are focused on a single segment: Medical and Healthcare Services. Investors closely monitor the Max Healthcare Institute share price to understand its performance and potential. Analyzing the Max Healthcare Institute business model provides insight into how the company generates revenue and manages its operations. Key factors influencing the stock include the company's financial results, earnings reports, and broader trends within the healthcare sector. Understanding these elements is crucial for evaluating the company's market position and future prospects.
Overview Daily Weekly

Key Takeaway

Max Healthcare shows mixed signals with positive momentum indicators (RSI 55.1, bullish MACD) but remains below its 200-day moving average, suggesting a neutral trend lacking strong conviction.

Daily

2026-05-08
  • The stock is exhibiting a neutral trend regime, trading slightly above its 50-day moving average by 0.76% but remains below the 200-day moving average, down by 4.46%. This suggests a mixed short-to-medium term outlook, with positive short-term momentum indicated by an RSI of 55.1 and a bullish MACD crossover, implying potential for upward movement if the price can overcome longer-term resistance.
  • Despite a sequential decline in net profit (-38.70%) and EPS (-38.81%) this quarter, the company demonstrated year-over-year growth, with net profit up 25.94% and EPS up 25.61%. This indicates underlying business resilience and recovery, even as short-term operational challenges may persist.
  • Analyst sentiment remains predominantly positive, with 77.3% of ratings being either 'Strong Buy' or 'Buy', and this distribution has been stable over the past month. This consensus suggests confidence in the company's future prospects among market experts.
  • Institutional investors, primarily FIIs and DIIs, hold a significant 71.71% stake. A notable shift occurred with FIIs reducing their holdings by 5.16% and DIIs increasing theirs by 5.12% quarter-over-quarter, indicating a potential reallocation of capital within domestic and foreign institutional circles.
  • The stock is currently trading 22.2% below its 52-week high, presenting a potential recovery opportunity, yet it is also 8.68% above its 52-week low. The current drawdown of -22.2% combined with average daily volume being below its 20-day average suggests lower conviction from market participants in the recent price action.
Open daily analysis

Weekly

Latest weekly signal
  • The stock price rose 1.91% this week, supported by an 8.31% increase in trading volume as it moved above its 50-day moving average.
  • Momentum indicators show a neutral to slightly positive sentiment, with the Relative Strength Index (RSI, a measure of price movement speed) at 55.10.
  • The company expanded its operational footprint by acquiring a 58.39% controlling stake in Kalinga Hospital Ltd. for 300 Crore.
  • Financial results for the quarter ending December 2025 showed a 10.7% year-on-year revenue increase, though the company faces a high valuation with a 139.8x PE ratio.
  • A GST demand of 55.20 crore against the company was withdrawn by the Department of Trade and Taxes, Delhi.
Open weekly analysis

Quarterly

Latest quarterly update
Detailed analysis available on the full page.

Price & Technical Structure

  • Short-term returns show a mixed picture, with a 1.91% gain over 5 days but a slight dip of -0.33% in the last day.
  • The trend regime is neutral, with the price trading slightly above the 50-day moving average (0.76%) but below the 200-day moving average (-4.46%).
  • Momentum indicators are positive, with an RSI of 55.1 and a bullish MACD crossover.
  • Volatility is moderate, with the price positioned around 67.68% of the way up the Bollinger Bands, and an annualized volatility of 20.26%.
  • The stock is trading 22.2% below its 52-week high and 8.68% above its 52-week low, with a current drawdown of -22.2%. Average daily volume is below its 20-day average, indicating lower conviction.
The market behaviour indicates a neutral trend with positive momentum. While short-term returns are mixed, the RSI and MACD suggest underlying strength. The stock is trading within its Bollinger Bands and has significant room to recover towards its 52-week high. However, lower average daily volume suggests a lack of strong conviction from market participants.

Weekly Momentum

  • The stock price rose 1.91% this week, supported by an 8.31% increase in trading volume as it moved above its 50-day moving average.
  • Momentum indicators show a neutral to slightly positive sentiment, with the Relative Strength Index (RSI, a measure of price movement speed) at 55.10.
  • The company expanded its operational footprint by acquiring a 58.39% controlling stake in Kalinga Hospital Ltd. for 300 Crore.
  • Financial results for the quarter ending December 2025 showed a 10.7% year-on-year revenue increase, though the company faces a high valuation with a 139.8x PE ratio.
  • A GST demand of 55.20 crore against the company was withdrawn by the Department of Trade and Taxes, Delhi.
Max Healthcare experienced a week of positive price action and strategic growth. The stock price climbed 1.91% on increased volume, successfully crossing above its 50-day moving average, which often signals improved medium-term momentum. While the technical landscape remains constrained by a broader downward trend relative to longer-term moving averages, the company's fundamental performance shows solid year-on-year growth in both revenue and net profit. The acquisition of a controlling stake in Kalinga Hospital and the resolution of a significant GST tax demand provide a clearer operational and regulatory outlook for the firm.